Diseases of the lips by Greenberg, Sophie A. et al.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Clinics in Dermatology   Editors: Nasim and Rogers  
Diseases of the Lips       
Sophie A. Greenberg, MD, Bethanee J. Schlosser, MD, PhD, Ginat W. Mirowski, DMD, 
MD 
Sophie A. Greenberg, MD  
Department of Dermatology 
Columbia University College of Physicians and Surgeons 
Herbert Irving Pavilion 
161 Fort Washington Ave 
New York, NY 10032 
sophieagreenberg@gmail.com 
415-971-9904 
Bethanee J. Schlosser, MD, PhD 
Associate Professor 
Director, Women's Skin Health Program 
Department of Dermatology 
Northwestern University Feinberg School of Medicine 
676 N St. Clair, Suite 1600 
Chicago, IL  60611 
BSchloss@nmff.org 
(404) 387-1611 
Ginat W. Mirowski, DMD, MD 
Adjunct Associate Professor, Department of Oral Pathology, Medicine, Radiology 
Indiana University School of Dentistry 
Volunteer Associate Professor, 
Department of Dermatology, 
Indiana University School of Medicine 
1121 W. Michigan St.  Rm S110 
Indianapolis IN 46202-5186 
317-797-0161 
Abstract  
Heath care providers should be comfortable with normal as well as pathologic findings in 
the lips as the lips are highly visible and may display symptoms of local as well as 
systemic inflammatory, allergic, irritant and neoplastic alterations. Fortunately, the lips 
are easily accessible. The evaluation should include a careful history and physical 
examination including visual inspection as well as palpation of the lips and an 
examination of associated cervical, submandibular and submental nodes. Pathologic and 
microscopic studies, as well as a review of medications, allergies and habits may further 
highlight possible etiologies. Many lip conditions, including premalignant changes are 
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relatively easy to treat when the abnormalities are detected early; however, advanced 
disease and malignancies are challenging for both the patient and clinician. Treatment 
should be focused on eliminating potential irritant or allergens and treatment of the 
primary dermatosis. In this article, we review physiologic variants as well as pathologic 
conditions of the lips. 
INTRODUCTION. 
Cheilitis refers to inflammatory, allergic, irritant, or neoplastic alterations of the lips 
occurs (Table 1). With inflammatory, allergic or irritant processes, patients complain of 
eroded or dry, cracked lips, that may or may not be swollen, but possibly painful or itchy. 
On physical examination, there may be slight edema to complete loss of the normal lip 
markings. With advanced inflammation, exfoliation, dry scale, and fissuring may occur.  
In contrast, neoplastic processes of the lips may be asymptomatic and present with mild 
color alteration, infiltration, nodularity, or ulceration (Table 2). Finally, it is not unusual 
for benign developmental variants of the lips to present with hypertrophy or swelling that 
raise concerns. 
Most lip conditions, including premalignant changes, are relatively easy to treat, if 
abnormalities are detected early; however, advanced disease and malignancies are 
challenging for both the patient and clinician. 
CLINICAL EVALUATION OF THE LIPS 
The lips are innervated by motor divisions of cranial nerve VII.  Lymphatic drainage is 
predominately to the submental and submandibular lymph nodes.  
The lips, as are other surfaces of the mouth, are subject to trauma from food, chewing, 
and various habits. These changes may be difficult to differentiate from inflammatory 
and premalignant or malignant changes including leukoplakia, erythroplakia, 
erythroleukoplakia, and non-healing erosions. Fortunately, lip conditions are amenable to 
various diagnostic procedures such as visualization, palpation, microbiologic evaluation 
and biopsy. Because systemic and dermatologic diseases occur on the lips with 
considerable frequency, biopsy specimens can frequently be taken from the vermilion as 
well as the labial oral mucosa more easily and with less visible scarring than skin 
biopsies.
1, 2
Evaluation should begin with a complete history and evaluation of the lips as well as the 
head and neck. Specific findings should focus on the history of onset and clinical course, 
followed by a thorough review of systems and complete mucocutaneous examination 
including the scalp/hair, palms, soles, nails and genitalia. A comprehensive review of 
topical and systemic medications, allergies and oral habits can be critical to targeting the 
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etiology of conditions of the lips. The history and examination findings should dictate 
further laboratory and/or histologic assessment.
1
 
 
EXAMINATION OF THE LIPS 
 
The lips should be evaluated both visually and digitally. The upper cutaneous lip extends 
from the base of the nasal columella to the vermilion border; the lower cutaneous lip 
extends from the vermilion border to the mental crease.  The vermilion border is the 
slightly raised, linear, palpable junction between the skin and the vermilion.  The 
vermilion of the lips is a hairless modified mucous membrane, pink to brown in color 
depending on the ethnicity, and covered by a thin dry stratified squamous epithelium. The 
lateral junction of the upper and lower vermilion lips defines the oral commissure (angle 
of the mouth). The labial mucosa begins at the wet-dry line where the vermilion and the 
mucosal junction meet. The labial mucosa is covered by nonkeratinized stratified 
squamous epithelium and extends to the sulcus of the dental arches.  
 
Bi-digital palpation of the lips permits appreciation of multiple, freely movable 2 - 4 mm 
papules within the substance of the upper and lower lips. These papules represent normal 
accessory (minor salivary glands) which secrete myxoid saliva directly onto the labial 
mucosa.
1
 To visualize the myxoid saliva, the clinician should gently dry off the mucosa 
using a piece of gauze as the lip is everted. Within 2-3 minutes, clear myxoid saliva pools 
on the surface of the lips. In contrast to the minor salivary glands, the paired major 
salivary glands express copious serous saliva from the parotid glands or mixed serous and 
myxoid saliva from the submandibular and sublingual glands.  
 
The presence and quality of saliva can be further assessed by drying off the buccal 
mucosa gently milking the parotid gland by pressing on the outside of the cheek from the 
angle of the mandible in an anterior fashion, all the while looking for extrusion of saliva 
at Stensen’s duct located across from the maxillary second molar. In contrast, saliva 
production by the submandibular and sublingual glands may be assessed by drying the 
floor of the mouth, pressing upwards at the submental/submandibular triangle, and 
inspecting for expression of saliva from Wharton’s duct.1 In patients with xerostomia, 
lack of myxoid or serous saliva pooling or cloudy saliva may be found. 
 
DEVELOPMENTAL CONDITIONS OF THE LIPS 
 
Lip prints, lip clefts, lip pits, and Fordyce granules 
 
Lip prints are normal patterns seen on the vermilion of the lips that appear as folds, 
wrinkles, and grooves. The vermilion overlies minor salivary glands, while sebaceous 
glands line the distal border adjacent to the skin. Oil and moisture from these glands 
maintain the health of the vermilion. Because lip prints, much like fingerprints, are 
unique to each individual, they are often used in investigations at crime scenes.
3
 Lip 
patterns do not alter with advancing age, inflammation, trauma, or environmental 
factors.
4
 Multiple classification schemas have been identified in lip prints determined by 
the linear patterns.
5, 6
 Lip prints even appear to be effective in gender differentiation.
6
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A number of developmental findings may be noted that help to understand the 
embryogenesis of lips. As the midface develops, the mandibular arch and the sulcus 
lateralis of the lower lip fuse. This is followed by fusion of the maxillary and nasofrontal 
processes. The most dramatic findings that are noted, when this normal process is 
interrupted are the development of clefts (1/700 births).
7
 Cleft lip(s) result when there is 
an interruption in the normal fusion of the embryologic plates that form the lips and the 
palate early during embryogenesis. 
 
 Clefts may be limited to the lips or extend into the anterior hard palate. Palatal clefts may 
involve the hard and/or soft palate. In embryogenesis, the palate and the lips develop 
independently, thus clefts of the lips can occur with or without involvement of the palate 
and vice versa, or they may occur together. Cleft lips are most often unilateral, however, 
in rare instances they may be bilateral. The etiology of clefts is multifactorial and 
includes genetic predisposition, exposure to medications such as 
anticonvulsants,
8
 isotretinoin,
9
 methotrexate,
10
 as well as complications secondary to viral 
infection (rubella).
11
 
 
Lip pits (Van der Woude Syndrome, VWS) are other congenital findings of the lips. Pits 
are most often inherited in an autosomal dominant fashion.
12
 These may occur in the 
setting of cleft lip and/or cleft palate or they may be independent. Pits may affect either 
the upper or more commonly, the lower lip and are most often located adjacent to the oral 
commissure or angle of the mouth. Pits may range in length from 1-25 mm and may 
involve the orbicularis muscle. Minor salivary glands may drain into these tracts resulting 
in mucous secretion from the pits.
13
 Surgical resection is curative.  
 
Fordyce granules (Fox-Fordyce spots) appear as small 1-3 mm yellow to orange or white 
papules. These ectopic sebaceous glands can be present on the vermilion of the lips, 
adjacent to the vermilion border, and more commonly on the labial and anterior buccal 
mucosa. They are often also found in the genital region.  
 
 
Pigmented macules of the lips 
 
Labial melanotic macules (focal melanosis) are benign pigmented macules on the 
vermilion. These pigmented macules may represent ephelides, post-inflammatory 
pigmentation, or the stigmata of Peutz-Jeghers syndrome or Addison disease. Melanotic 
macules may appear on any mucosal surface, however, most commonly are seen on the 
vermilion, palate, buccal mucosa, and gingiva. Macules may be blue, black, or brown. 
Typically, labial melanotic macules are solitary lesions, but multiple macules can occur. 
The labial melanotic macules are usually well-circumscribed and have an average 
diameter of 4-6 mm. Labial melanotic macules occur more frequently in women, and 
based on the authors’ clinical experience may be more common in patients of Asian 
descent.  
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In labial melanotic macules, melanin accumulates in the basal keratinocytes without an 
increase in the number of melanocytes. Melanin in the lamina propria and 
melanophagocytosis may also be present. In contrast to oral nevi and malignant 
melanoma, labial melanotic macules are HMB-45 negative. Labial melanotic macules are 
asymptomatic and have no malignant potential.  
 
Various medications may also cause macular pigmentation 
14
 Any lesion in question or 
those that are ulcerated, exophytic or variably pigmented should be excised to exclude 
malignant melanoma.  
 
Hyperpigmented lesions of the lips and other mucosal sites are frequently encountered on 
routine examination.  The significance of these lesions spans a wide gamut from a 
variation of normal to being a sign of an underlying life-threatening anomaly. The history 
and physical examination will help focus on possible conditions.  
 
Physiologic melanoplakia is common in dark skinned individuals.  
 Peutz-Jeghers syndrome is an autosomal dominant condition characterized by macular 
hyperpigmentation in early childhood and by hamartomatous polyps of the gastrointestinal tract.
15
 
 Addison disease, or primary adrenal insufficiency, is characterized by diffuse hyperpigmentation 
of the skin and oral hyperpigmentation with a predilection for traumatized areas and skin folds as 
well as systemic findings that include weight loss, fatigue, hypotension and electrolyte 
abnormalities.
16
  
 Albright syndrome is characterized by a triad of polyostotic fibrous dysplasia, precocious puberty, 
and pigmentary abnormalities of the lips.  
 Laugier-Hunziker syndrome, a benign acquired syndrome, is characterized by solitary or confluent 
pigmented macules whose color may vary from gray to brown to blue-black.
17-19
 These macules 
are commonly seen on the lower lip, hard palate and the tips of the fingers. The labial 
commissures, the gingiva and the floor of the mouth are less frequently involved.
19
 Involvement of 
the fingernails, toenails and genitalia or perineum have been reported.
20
 The nail  pigmentation 
may appear as a single longitudinal streak; a double longitudinal streak in the lateral parts of the 
nail plate; or as homogeneous pigmentation of the radial or ulnar half of the nail.  
In contrast to Peutz-Jeghers syndrome, Albright syndrome and Addison disease, 
there are no associated internal manifestations with Laugier-Hunziker syndrome.  
Histologically, Laugier-Hunziker syndrome is characterized by increased 
melanization of the basal keratinocytes and by an increased number of 
melanophages in the upper dermis. The melanocytes demonstrate normal 
morphology and number. 
 
Lentigines are common brown macules that may appear on the palate, gingiva, and lips. 
They may be related to age and ultraviolet light exposure or may be seen in the setting of 
multiple lentigines syndrome (formerly termed LEOPARD syndrome). Microscopically, 
benign melanocyte hyperplasia is seen in conjunction with elongation of the rete ridges. 
Oral lentigines are probably not related to melanomas; however, if a labial melanotic 
macule enlarges one must consider lentigo maligna in the differential. Lentigo maligna, a 
rare form of malignant melanoma is typically found in Caucasian women. Lentigo 
maligna melanoma presents on the head and neck on sun exposed skin. Rarely, this tumor 
may extend onto the lips.
21
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Vascular Findings 
 
Venous Lakes 
 
Venous lakes of the lips are common blanchable blue to purple macules or papules that 
range in size from 2-8 mm. The lower lip is more commonly affected than the upper lip. 
The prevalence of these asymptomatic findings increases with advancing age and with 
sun exposure. Histologically, a single layer of flattened endothelial cells surrounded by 
relatively thick fibrous tissue is noted. No treatment is indicated as these rarely bleed but 
may be cosmetically offensive. In such cases, PDL laser or surgical excisions are 
effective.
22
 
 
Caliber Persistent Artery 
 
When evaluating the mucosal surface of the lip, a superficial tortuous vessel may be 
visible and is termed caliber persistent artery.
23
 This common vascular anomaly occurs 
on the lower lip 80% of the time, but the upper lip and palate may also be affected. This 
developmental anomaly occurs when the inferior alveolar artery fails to taper as it exits 
the mental foramen and progresses superficially. The size and superficial location make 
the caliber persistent artery palpable, usually a few millimeters inferior to the vermilion 
border. Occasionally, it may appear as a sessile elongated nodule of variable size, which 
may raise concern for a benign or malignant tumor. Noninvasive high-resolution Doppler 
ultrasound may confirm the presence of an artery eliminating the need for biopsy.
24
  
 
When the area is excised, the pathology reveals only a large artery with a thick, smooth 
muscle wall that is surrounded by variable fibrovascular connective tissue and stratified 
squamous epithelium. Pathologists should be made aware of the clinical differential, as 
the in vivo dilatation collapses upon excision thus appearing as a normal artery or 
arteriole with no visible pathology. Surgical excision may be associated with 
considerable bleeding that requires ligation of both transected vessel ends. In general, no 
treatment is indicated; some authors suggest that the finding of a caliber persistent artery 
on the lip may herald similar dilated arteries in the gastrointestinal tract associated with 
potentially lethal hemorrhage.
25
 
 
TRAUMA-ASSOCIATED FINDINGS OF THE LIPS 
 
Morsicatio Labiorum 
 
Morsicatio labiorum (chronic nibbling of lips) is a self-inflicted mechanical alteration or 
habit that results from biting or sucking the lip. Morsicatio labiorum is more frequently 
noted on the lower lip than on the upper lip and presents with shredded or verrucous 
white plaques, zones of erythema, and erosions. 
26
 The shredded epithelium may be 
peeled off by the patient resulting in further trauma and ulceration. Frequently, the 
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 7 
anterior 1/3 of the buccal mucosa (morsicatio buccarum et labiorum) and/or lateral border 
of the tongue (morsicatio linguarum et labiorum) are also affected.
27, 28
 
 
The patient may or may not be aware of his/her habit, but often, a family member or 
partner may be able to provide insight.  Further questioning may also reveal concurrent 
stress, anxiety or other compulsive tendencies. Bilateral and often symmetric 
involvement in areas that are reachable by the teeth is diagnostic. In the context of the 
characteristic clinical presentation and distribution, a biopsy is unnecessary. If the 
presentation is not classic, then a biopsy should be performed. 
 
The histopathology of morsicatio is diagnostic and exhibits an acanthotic and 
hyperkeratotic epithelium.
29
 Numerous keratin projections are lined by basophilic 
bacterial organisms. Clusters of vacuolated keratinocytes may be present in the spinous 
cell layer. Special staining for fungi is negative. Microbial culture provides no benefit. 
The differential diagnosis includes oral pseudomembranous candidiasis, oral hairy 
leukoplakia and white sponge nevus of Cannon. Treatment, if desired, involves 
behavioral modification only. 
 
Mucoceles 
 
A mucocele is a benign pathologic entity of the minor salivary glands that result in 
myxoid saliva accumulation below the mucosal surface.
30, 31
 Clinically, most mucoceles 
appear as a single but often recurrent, translucent, fluctuant 0.5-1.5 cm cyst-like pink, 
papular swelling on the lower lip. Other locations include the floor of the mouth, buccal 
mucosa, ventral tongue or soft palate. Due to the Tyndall effect, some mucoceles may 
appear bluish in color. The patient may note a thick myxoid/sweet-tasting extravasation 
with rupture of the mucocele. With repeated episodes, fibrous scarring may spread to 
adjacent glands with potential increased nodularity. 
 
Two distinct mechanisms come into play in the onset of mucoceles. More commonly, 
mucoceles may result from traumatic rupture of a minor salivary gland duct with spillage 
into the surrounding submucosa (extravasation type).  Less often, the minor salivary duct 
may become obstructed due to a stone (sialolith) resulting in retrograde accumulation of 
saliva within an epithelial capsule just below the mucosal surface (retention type). 
 
The differential diagnosis includes a benign or malignant salivary gland neoplasm, 
hemangioma, lymphangioma, soft tissue abscess, lipoma, pyogenic granuloma or 
fibroepithelial polyp. Rarely, a limited manifestation of pemphigoid, pemphigus vulgaris, 
or herpes simplex virus infection may be considered, but the history and histopathology 
are diagnostic. Treatment, if necessary, includes excision, cryotherapy, or local 
administration of corticosteroids, all of which have been reported with mixed results. 
  
INFECTIOUS AND INFLAMATORY DISORDERS OF THE LIPS   
 
Angular cheilitis 
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Angular cheilitis (angular cheilosis, angular stomatitis, perlèche, derived from the French 
lécher meaning to lick) is characterized by painful fissures of the oral commissure(s) that 
extend from the mucosal surface to the cutaneous skin; maceration, erythema, crust and 
scale are often present. The pathogenesis is often multifactorial. Unilateral involvement 
tends to be short-lived and has been attributed most often to local trauma. (Figure 1) 
 
Bilateral disease is often chronic and suggests an anatomic abnormality with overclosure 
of the mouth, irritant reactions, infections, inflammatory dermatoses and/or nutritional 
deficiencies.
32
 Anatomic abnormalities in patients with ill-fitting dentures, malocclusion 
of the natural teeth and/or overclosure of the teeth predisposes to pooling of saliva at the 
commissures. Inadequate support of the lips, reduced occlusal vertical dimension and 
formation of static marionette lines with aging are additional risk factors.  
 
Habitual lip licking (Figure 2), thumb sucking, lip biting and improper flossing may also 
predispose to angular cheilitis.
33
 Patients undergoing orthodontic treatment may be 
susceptible due to contact allergy;
34
 however, good oral hygiene reduces the risk of 
angular cheilitis in this population.
35
 Particularly, in patients younger than 35 years old, 
angular cheilitis may be a presentation of oral psoriasis.
36
 Angular cheilitis may also 
result from deficiencies in riboflavin (B2), niacin (B3), pyridoxine (B6), biotin (B7), folic 
acid (B9), cyanocobalamin (B12), iron, and zinc.
32, 37
 
 
Medications rarely directly cause angular cheilitis.
38
 Medications are more likely, 
however, to cause xerostomia (eg. anti-cholinergics) or exfoliative cheilitis (eg. 
isotretinoin, indinavir) and thereby predispose to the development of angular cheilitis.
39, 
40
 
 
The clinical differential diagnosis of angular cheilitis includes herpes labialis, impetigo, 
irritant cheilitis (lip licker’s dermatitis), actinic cheilitis, allergic contact cheilitis, perioral 
dermatitis, verruca vulgaris, split papules of secondary syphilis and squamous cell 
carcinoma. 
 
Initial management is aimed at identifying and rectifying any precipitating factors. 
Treatment should be tailored to the specific cause(s) identified. Dentures and other dental 
prostheses (such as partials) should be evaluated by the dentist for appropriate fit, and the 
dentition should be examined for proper occlusion. Oral hygiene regimens should be 
reviewed and revised as needed. Local skin irritation may be minimized by the frequent 
use of barrier agents such as petrolatum. 
 
 Xerostomia should be addressed with lifestyle measures and/or pharmacologic therapy. 
Topical formulations of antifungal agents with or without antibiotics may be effective in 
immunocompetent hosts. In patients with evidence of intraoral candidiasis, who are 
immunosuppressed or who fail to respond to topical therapy, systemic antifungal 
treatment should be implemented.
41
 Antibiotic therapy should be directed against specific 
cultured organisms. For cases involving Staphylococcus or Streptococcus species, 
mupirocin ointment 2% is the treatment of choice. In cases of refractory or chronic 
angular cheilitis, patients should be evaluated for underlying systemic disease, including 
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 9 
diabetes mellitus, anemia, Crohn disease, HIV infection, nutritional deficiency,  and 
malignancy.
42
  
 
 
 
Herpes Labialis 
 
Herpes simplex virus (HSV), a double stranded DNA virus, is one of the most common 
infections worldwide. Two strains of HSV have been identified. HSV-1 accounts for 
nearly all cases of oral herpes while most genital infections are due to HSV-2. Each strain 
may cause infections at either site, though it is rare for HSV-2 to cause recurrent herpes 
labialis.
43
 HSV-1 seropositivity rates range from 60%-90% worldwide.
43-45
  
 
Primary infection may present with pain, cheilitis, perioral vesicles, gingivostomatitis, 
pharyngitis, fever, and coryza, especially in young children. Most cases of primary HSV 
infection are asymptomatic, subclinical, or misdiagnosed as a nonspecific viral illness. 
Following the initial infection, the virus lies dormant in the sensory trigeminal ganglia. 
Reactivation (secondary infection) presents with a prodrome of pain and or tingling 
associated with local edema and a headache. This is followed by the emergence, within a 
day or two, of grouped clear papulovesicles. Over the next 5-10 days, the vesicles erode,  
crust and then resolve. Recurrent herpes labialis most commonly occurs on the vermilion 
and vermilion border (keratinized surfaces).  
 
Triggers for recurrent herpes labialis may include: ultraviolet light, wind, trauma (e.g. 
dental procedures), stress, severe drug eruptions, menstruation, and fever.
46
 
Immunocompetent hosts may have a primary infection without any clinically apparent 
recurrences. 
47
 Most patients with recurrent herpes labialis have two episodes per year; 
however, 5%–10% of patients may have six recurrences or more per year. Secondary 
impetiginization of herpes labialis is common. 
 
Immunocompromised hosts tend to have more severe and more frequent recurrences.
48
 
Both the WHO and the CDC classify a chronic herpetic mucocutaneous ulceration lasting 
more than one month as an AIDS defining illness. Rarely, HSV can cause systemic 
complications including encephalitis, meningitis, and eczema herpeticum.
43
 Other clinical 
manifestations of HSV infection include herpetic whitlow, herpes gladiatorum, ocular 
herpes virus infections with risk of secondary corneal blindness.
43
  
 
The differential diagnosis for HSV infection is based on the location and clinical course. 
Aphthous ulcers generally occur on nonkeratinized mucosa, and therefore not on the 
vermilion but recurrent HSV lesions typically occur on the keratinized mucosa of the lips. 
When HSV-1 is secondarily infected, impetigo may also be considered in the differential 
diagnosis. In immunosuppressed individuals with extensive disease, vesiculobullous 
disorders should also be considered. 
   
The diagnosis of HSV infections can be confirmed with viral culture, direct fluorescent 
antibody studies (DFA), or viral polymerase chain reaction techniques (PCR). A Tzanck 
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smear assesses the presence of multinucleated giant cells. It is performed by unroofing a 
vesicle, using a #15 blade to scrape the base of the lesion, and placing the scraping on a 
glass slide. The smear is then counterstained with Giemsa, Wright, or Papanicolaou stain. 
The presence of multinucleated giant cells with molded nuclei is suggestive but not 
specific of HSV infection, as these may also be present in varicella-zoster virus infections 
(VZV).
43
 Other herpes viruses (such as the Epstein Barr virus, cytomegalovirus, 
exanthem subitum virus, or Kaposi sarcoma virus) that commonly affect the oral cavity 
are less likely to present with lip involvement .  
 
Serologic testing for HSV demonstrates a high prevalence and is more sensitive than a 
patient’s history due to asymptomatic or subclinical disease.45 One study demonstrated 
that only 6%-8% of patients with a history of herpes labialis were seropositive for HSV-2 
only.
49
 Up to 40% of HSV-1 seropositive patients have a history of symptoms of 
orolabial infection.
43
 Another study showed that in the US, 20%-25% of adults are 
seropositive for HSV-2, though many are subclinical/asymptomatic with 90% denying 
any prior history of a genital HSV infection.
43, 50
 
 
Primary HSV infections  may be treated with acyclovir 400 mg PO five times daily for 5 
days (both for adults and older children) or valacyclovir 1g BID for 10 days to shorten 
the duration of oral lesions and reduce viral shedding.
43,51
 There are no data to support 
using famciclovir for treatment of primary HSV infection.
52
  
 
Recurrent herpes labialis may be treated with antiviral agents when patients have frequent 
or persistent outbreaks. Treatment during the prodromal phase has been shown to 
decrease the duration of outbreaks and even prevent lesion formation.
43
 Appropriate 
regimens include: acyclovir 200 mg five times daily for 5 days (decreases symptom 
duration), famciclovir 125 mg BID for 5-7 days (decreases duration of lesions), or 
valacyclovir 2000 mg BID for 1 day.
52
  
 
Chronic suppressive therapy has been shown to prevent outbreaks, decrease viral 
shedding, and possibly reduce transmission.
43
 Appropriate chronic suppression regimens 
include: acyclovir 400 mg BID, famciclovir 250 mg BID or valacyclovir 1000 mg QD.
52
 
Thrombotic thrombocytopenic purpura is a serious potential side effect especially with 
long term use of valacyclovir in patients with 
advanced HIV disease.
43
 
 
Topical antivirals have not been shown to provide 
more benefit than placebo in treating recurrent infections or preventing attacks;
46
 
however, a novel agent, Acyclovir Lauriad, a muco-adhesive tablet applied to the gingiva 
at the onset of prodromal symptoms, has been shown to be effective. It reduces duration 
(by an average of one day) and incidence of episodes, aborts episodes, and increases time 
to next recurrence.
53
  
 
Laser phototherapy has been shown to decrease pain, increase disease free intervals, viral 
titer, and drainage from the vesicles.
54
 Lasers do not completely eliminate HSV and its 
recurrences, the process may be painful for patients, and it is unlikely to be covered by 
Is this a problem for other patients? Not 
typically (gmw) 
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insurance.
54
 One major advantage of laser treatment is that there are no side effects and 
that drug-drug interactions may be avoided.
54
 
 
Patients should avoid triggers, when possible, for example, by avoiding sun exposure, 
stress, wind, and trauma. Sunscreen use has been shown in several studies to reduce the 
frequency of recurrence of herpes labialis.
46
 Patients may also take short-term 
prophylactic therapy prior to events known to initiate a recurrence, such as a dental 
procedure or skiing.
43
   Secondary conditions, such as atopic dermatitis, should be treated 
early and aggressively. 
 
Other viral infections of the lips 
 
The human papilloma virus (HPV) is a naked double-stranded DNA virus that causes 
verrucous papules (squamous papillomas, verruca vulgaris, and focal epithelial 
hyperplasia or Heck disease). The association with labial SCC has not been confirmed, 
despite such an association with genital SCC.   
 
Molluscum contagiosum is a viral disease due to the poxvirus, a DNA virus. Clinically, 
umbilicated papules with a central dell may affect the skin as well as the vermillion of the 
lip. Histologically, intracytoplasmic inclusion bodies (Henderson-Paterson bodies) are 
pathognomonic in cytological smears. Immunocompromised patients are particularly at 
risk for chronic labial involvement.   
 
 
 
INFLAMMATORY DERMATOSES OF THE LIPS 
 
Exfoliative Cheilitis 
  
Exfoliative cheilitis is a nonspecific term that describes several chronic conditions. It is 
characterized by chronic scale and irritation of the vermilion with the lower lip often 
more severely affected than the upper lip (chronic chapped lips). Patients may complain 
of dryness, itching, or tingling. Numerous causes of exfoliative lip findings include 
inflammatory dermatoses, such as atopic dermatitis (AD), psoriasis, and chronic irritant 
or allergic reaction to cosmetics and or flavorings (Table 1). Exacerbating factors include 
stress, chronic mouth breathing, lip licking or sucking, and lip picking or biting. 
Treatment with topical corticosteroids and topical calcineurin inhibitors may be effective 
depending on the underlying etiology. Secondary impetiginization may complicate the 
clinical presentation and must be treated.  
 
 Atopic Cheilitis  
 
AD is a common chronic pruritic condition that waxes and wanes. Patients with an atopic 
diathesis, which includes asthma, allergic rhinitis, and dermatitis, are commonly affected. 
Cutaneous clinical findings range from acute eczematous vesicular eruptions to subacute 
crusting and scaly rashes. AD is a very common associated diagnosis in children with 
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cheilitis.   Cheilitis is one of the minor criteria  in the Hanafin-Ruska criteria for 
diagnosing AD. 
56 
Chronic changes of the perioral skin and lichenification in the setting 
of an atopic history may be the only clues to the diagnosis. Suggestive serologic studies 
include eosinophilia and elevated serum  IgE level; no diagnostic laboratory tests are 
available. Some authorities have suggested that a median fissure of the vermilion is 
highly suggestive.
55, 56
 In patients with AD, the exposure to HSV may result in the 
generalized, life-threatening condition eczema herpeticum, (Kaposi’s varicelliform 
eruption). 
 
Allergic Contact Cheilitis 
  
Contact cheilitis is characterized by circumoral edema, erythema, irritation, and or scale 
that may involve both lips as well as the surrounding skin. Contact cheilitis may be due to 
an immunologic allergic reaction or more commonly may be due to an irritant reaction 
(Table 3).  Likely culprits include personal care products, balms, aerosol products, 
medicaments or foods.  
  
The most common causes of contact cheilitis include the use of personal hygiene 
products such as toothpastes and mouthwashes, which contain numerous anti-bacterial 
agents, essential oils, and preservatives.
57,58
 Mouthwashes also contain alcohols and 
propylene glycol.
59
 It is hypothesized that saliva contributes to dilution or elimination of 
allergens resulting in lip involvement without intraoral findings.  Personal care products 
often contain a long list of ingredients including menthol, clove oil, pimento oil, anise oil, 
camphor, phenol, lanolin, cocoa butter, salicylic acid, vitamin E, Shea butter, and 
sunscreens. Not all ingredients are present in all formulations. A subtle source of 
exposure to irritants and allergens are the personal care products of partners.
60
 
 
Cosmetics, including lipstick, lip gloss, salves/balms and emollients, contain flavoring, 
dyes, preservatives/antioxidants, and sunscreens, as well as perfumes and pigments, 
which can cause contact cheilitis.
61
 Hair sprays, facial creams and lotions, as well as nail 
polish, can also contribute to lip reactions. Foods, including carrots, orange peel, mango 
peels, coffee, and menthol, as well as cloves, curry, vanilla, nutmeg, paprika, mint, and 
others and, flavorings such as Myroxylon pareira (balsam of Peru), citral, 
cinnamaldehyde, peppermint oil, and geraniol, are well documented causes of cheilitis.
57, 
62
 Ricinoleic acid, a constituent of castor oil, has been identified as the commonest 
current cause of allergic contact cheilitis due to lip cosmetics.
63
 Chewing gums and 
candies also contain many flavorings and thus are other common causes of contact 
cheilitis. 
 
Personal habits, such as the use of nail polish and, cigarette holders, mouth guards, or 
chewing on pencil and pencil erasers, (rubber or nickel) and hairpins or metal tools, may 
result in cheilitis. Musicians who place their instruments in the mouth, such as wind and 
reed players, are particularly susceptible to the development of both irritant and allergic 
cheilitis.
64,65, 66
 Topical medications including corticosteroids, benzocaine, and antibiotics 
have resulted in iatrogenic induction of cheilitis.
62
 The use of dental materials, such as 
rubber dams and rubber accelerators in the fabrication of dentures as well as the presence 
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of eugenol in periodontal dressings and impression pastes, may contribute to acute 
cheilitis.  Lastly, even if the patient is not using any suspicious agents, connubial 
exposure can result in cheilitis.  
 
Treatment should focus on changing or discontinuing any suspicious products. 
Suspicious foods, candies and gums or cosmetics should be eliminated.  All dental, 
orthodontic. or athletic appliances should be withheld and then reintroduced one at a time 
once the cheilitis has resolved. To help identify specific allergens, patch tests or use tests 
should be performed. Material data sheets may be obtained to further direct the clinician 
to likely allergens in braces or wires, which may contain nickel. Then, the dentist or 
orthodontist will need to identify non-nickel alternatives and remove offending 
appliances. The use of topical cortocosteroid ointment BID to QID and emollients should 
also be recommended. One caveat is that, allergic contact cheilitis can be caused by 
topical corticosteroids or emollients as well as preservatives and flavorings.  When the 
lips get worse rather than better, consider an allergic contact reaction to the topical 
emollient or corticosteroid.  
 
The histopathology of contact cheilitis reveals a nonspecific acute or chronic lichenoid 
dermatitis or mucositis with or without the presence of eosinophils and plasma cells.  
 
Cutaneous patch testing is an essential part of diagnosing presumed allergic contact 
dermatitis.  The North American Contact Dermatitis Group recommends a standard panel 
that is comprised of a series of allergens that includes common fragrances, metals, 
preservatives, and medications,
67
 
  
 Lupus erythematosus 
 
Discoid lupus erythematosus (DLE) is the most common manifestation of lupus 
erythematosus. DLE typically present on the skin but may also present in the oral cavity 
and affect the lips.
68
 (Figure 3) Most patients present in their early 50’s with a female 
predilection of 8:1. Distinctive oral plaques of DLE appear as “sunburst” red and white 
plaques with characteristic peripheral radiating striations on the buccal and labial 
mucosal. Red and white oval plaques may also affect the vermilion.
69
 Although both lips 
may be affected, the lower lip, possibly due to increased trauma or increased exposure to 
UV light, is affected in 71% of cases.
68, 70
  
 
The clinical picture of DLE is nonspecific. Patients present with whitish lichenoid 
papules and plaques on the vermilion typically in the setting of either cutaneous and or 
intraoral involvement. This picture may be difficult to distinguish from lichen planus or 
even actinic cheilitis; however, despite this benign appearance, DLE of the lips can be 
associated with malignant transformation as documented in numerous studies.
71
 In a 
literature review, almost half of SCC that arose in patients with DLE had lip SCC.
72
 
Associated risk factors such as smoking and alcohol, use were not found to be 
significant.
71
  
 
Aggressive sun protection is needed in these patients. A biopsy is indicated due to the 
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aggressive nature if malignant transformation should occur.  
 
Sjögren Disease and Xerostomia 
 
Sjögren disease (SD) is an autoimmune systemic disease characterized by a dry mouth 
and dry eyes. Patients may have mild dryness of the lips. Multiorgan system disease can 
occur including the central nervous system, lungs, kidneys, GI tract, liver, pancreas, 
joints, and vasculature. SD is one of the most prevalent autoimmune disorders with 3.9 
per 100,000 affected in the U.S.
73
 Nine out of 10 patients are women.
74
 
Sjögren disease may occur in isolation (50% of patients) or in conjunction with other 
autoimmune connective tissue disease, such as rheumatoid arthritis, lupus erythematosus, 
or scleroderma. 
 
Decreased salivary flow may result in difficulties with speaking or eating and may be 
quite painful. Symptoms may remain steady, worsen, or remit over time. Symptoms and 
signs of SD may be nonspecific and subtle resulting in a delay of diagnosis or 
misdiagnosis with an average delay of 4.7 years.
75,76
 SD patients are at risk for a variety 
of complications including weight loss, nutritional deficiencies, dental caries, and oral 
candidiasis. Early diagnosis and proper treatment may reduce serious complications and 
often improve patients’ quality of life. 
 
Diagnosis of Sjögren disease is made by performing a minor salivary gland biopsy 
2,77
  
For optimal diagnosis and care, multispecialty collaboration and communication 
including dermatology, ophthalmology, dentistry, gynecology, and others based on the 
clinical situation is essential. 
 
Symptomatic care should include applying emollients on the lips, drinking 8 cups of 
water per day (adding 1-2 teaspoons of lemon juice per 16 ounces will increase salivary 
flow), avoidance of excess sugar, sucking on sugar free lemon drops or chewing 
sugarless gum, and maintaining meticulous oral hygiene. Two FDA approved 
sialogogues can be helpful are cevimeline (Evoxac ®) 30 mg TID and pilocarpine 
(Salagen ®) 5 mg TID; however, the side effects of sweating, rhinitis, nausea, diarrhea, 
or visual disturbances may limit their use.  
 
Cheilitis Glandularis 
 
Cheilitis glandularis is a rare inflammatory disease of the minor salivary glands. Patients 
complain of thick, bumpy lip(s). This disease preferentially affects the lower lip. Cheilitis 
glandularis tends to preferentially affect light-skinned individuals and males.
77
 It mainly 
affects adults, though case reports in children and adolescents are documented.
78
 
Clinically, the lips appear swollen with red, dilated salivary gland orifices that express 
thick, myxoid saliva onto the vermilion.
79
  Submucosal papules and nodules are evident 
on palpation.
77
  
 
Numerous etiologic causes have been proposed but recently, dysfunction of aquaporin, a 
membrane protein that plays a role in water and small solute transport and homeostasis, 
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has been reported.
80
 Alteration of water transport may alter salivary composition, leading 
to changes in the salivary gland environment.
80
 
 
The differential diagnosis includes cheilitis granulomatosa, salivary gland neoplasms, 
actinic cheilitis or SCC of the lip, or chronic habitual injury. Cheilitis apostematosa 
profunda is a variant in which the salivary glands express a suppurative discharge.
77
 
 
Lip biopsy helps exclude neoplastic or granulomatous conditions.  Characteristic features 
of cheilitis glandularis include histopathologic findings of chronic sialadenitis and dilated 
acinar lobules and ducts.
77, 81
 In vivo confocal microscopy may also be useful as it has 
been shown to correlate with the clinical and histopathologic evaluation of cheilitis 
glandularis.
82
 
 
Treatment includes topical or intralesional corticosteroids or oral antibiotics.
83
 Surgical 
excision of the vermilion may be considered for severe or refractory cases.
83
 Patients also 
must practice sun protection with sun avoidance and sunscreen.  
 
Psoriasis  
 
Oral psoriasis is uncommon. (84-86) Psoriasis, a chronic and well-recognized condition 
of the skin characterized by erythematous patches or plaques covered by silvery scale, 
occurs in about 1%-3% of adults.
87
 Classic involvement occurs on the scalp, elbows, and 
knees, though all skin sites can be affected including the nails and genitalia. Intraoral 
psoriasis is rare even in focused populations with underlying psoriasis.
86
  
 
Intraoral psoriasis and psoriasis of the lips remain a poorly recognized entity particularly 
in the absence of cutaneous involvement. Case reports and small series suggest that oral 
psoriasis may appear as migratory erythema, erosions, or pustular plaques, which are 
similar to geographic tongue/stomatitis. Some, but not all, experts believe that intraoral 
psoriasis and geographic stomatitis are one and the same condition.
36, 88
  
 
Psoriasis of the vermilion lips presents as nonspecific erythema, scaling, cracking or 
pustules.
85
  There are several clinical presentations including typical scaly erythematous 
psoriatic plaques that may extend across the vermilion border to the perioral cutaneous 
skin while also extending to involve the labial mucosa.
36
 Psoriasis of the vermilion lips 
may also present as exfoliative cheilitis and angular cheilitis. Exfoliative cheilitis exhibits 
diffuse scaling and fissures oriented perpendicular to the vermilion border; this subtype 
may correlate with the clinical activity of psoriasis vulgaris and pustular psoriasis.
36, 84, 86
 
Traumatic involvement due to malalignment and malocclusion of the teeth or recurrent 
traumatic manipulation can exacerbate psoriasis due to the Koebner phenomenon. 
 
The clinical differential diagnosis of psoriasis of the lips includes allergic contact 
cheilitis, lip licker’s dermatitis (Figure 2), lichen planus, lupus erythematosus, 
candidiasis, Reiter syndrome, and pyostomatitis vegetans. The histologic findings of lip 
psoriasis are nonspecific and resemble the neutrophilic microabscess and intraepidermal 
spongiosis of geographic tongue or pyostomatitis vegetans.
85, 88
 KOH microscopy and/or 
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fungal culture may confirm oral candidiasis, however negative KOH microscopy does not 
exclude a diagnosis of oral candidiasis. 
 
Treatment with mid to high potency topical corticosteroid ointments, such as desonide 
0.05% or clobetasol 0.05% ointment, is the treatment of choice in addition to the liberal 
use of emollients. Clinicians should monitor for the development of acne rosacea, 
perioral dermatitis, and cutaneous atrophy including telangiectasia and striae with long-
term use of topical corticosteroids. Secondary candidiasis or HSV labialis must be 
considered in the setting of acute exacerbation of symptoms.  
 
Drug associated cheilitis  
 
Drug associated cheilitis is common particularly in the setting of isotretinoin use.
89
 Other 
agents that may cause cheilitis medicamentosa include anticholinergics, antihistamines, 
antidepressant, antidiuretics, and antihypertensives by the mechanism of  xerostomia. 
Anticonvulsants, antineoplastics, antipsychotics, and narcotics may be associated with 
lichenoid drug reactions ,phototoxic cheilitis,, erythema multiforme , SJS, or angioedema 
involving the lips. 
38
  
 
 
NEOPLASTIC CONDITIONS OF THE LIPS 
 
Clinically, inflammation of the vermilion may be difficult to differentiate from 
premalignant conditions as both may present with erythema with linear lichenoid macules 
or reticulated plaques at the vermilion. Plaques or patches of white or pale vermilion may 
represent sun-induced changes that could be associated solar keratosis, dysplasia, or 
carcinoma. Small 1-3 mm pigmented macules may represent a benign process such as a 
melanotic macule. Changing color or growth into larger melanotic macules and papules 
warrant evaluation to exclude melanoma.
  
A biopsy to evaluate these changes is indicated 
to differentiate inflammatory from premalignant or malignant changes (Table 2). 
 
Actinic Cheilitis 
 
Actinic cheilitis (actinic keratosis of the lip, solar cheilosis) is a premalignant condition 
associated with chronic exposure to solar/ultraviolet radiation. Actinic cheilitis precedes 
the development of squamous cell carcinoma of the lip.  
 
Prevalence rates of actinic cheilitis range from 0.5%-2.4% of the population with 
prevalence rate being substantially higher for populations chronically engaged in outdoor 
activities.
90, 91
 Fair-skinned individuals (Fitzpatrick phototypes I, II) and/or those who 
work outdoors (i.e. farmers, fisherman, construction workers) are most predisposed but 
are not exclusively affected. Men are more commonly affected than women. This is 
hypothesized to be due to increased frequency of outdoor occupations and/or less 
rigorous sun protection behaviors.
92
 Additional risk factors include age (>35 years old), 
lower socioeconomic status, smoking and genetic predisposition.
90, 93
 Solid organ 
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transplant recipients have a higher prevalence of dysplasia, leukoplakia, and SCC of the 
lip due to their immunosuppressed status.
94, 95
 
  
Actinic cheilitis may vary from asymptomatic to pain and swelling of the lips and the 
development of scaly crust on the vermilion. Actinic cheilitis most frequently affects the 
lower lip as the upper lip is relatively shaded from UV exposure. Diffuse erythema, 
patchy whiteness, dryness and scaling of the vermilion typify actinic cheilitis. Fissuring, 
atrophy and loss of the normal lip lines may also be noted. Loss and blurring of the 
vermilion border is clinically characteristic but may be difficult to discern in elderly 
patients with associated loss of support structures of the lip. Pain and irritation may be 
minimal even in the setting of ulceration. Although the appearance of the vermilion may 
be non-uniform with discrete areas of hyperkeratosis, the presence of induration or 
ulceration require further evaluation for squamous cell carcinoma. Patients should also be 
assessed for the presence of cervical lymphadenopathy (unilateral vs. bilateral, mobile vs. 
fixed) prior to any diagnostic or therapeutic intervention. 
 
The clinical differential diagnosis of actinic cheilitis includes cheilitis glandularis, contact 
cheilitis, exfoliative/atopic cheilitis, lichen planus, lupus erythematosus, and squamous 
cell carcinoma. One or more biopsies should be obtained from any area of ulceration, 
induration, nodularity or hyperkeratosis to exclude malignancy as any single biopsy may 
not be representative of epithelial dysplasia at non-sampled sites. 
 
The histopathology of actinic cheilitis demonstrates epithelial hyperplasia, parakeratosis, 
and variable degrees of epithelial dysplasia as well as chronic inflammatory infiltrate, 
solar elastosis, and vasodilatation. The degree of epithelial dysplasia cannot be predicted 
by clinical presentation.
96, 97
  
 
Several medical and procedural therapies exist for actinic cheilitis. The need for rigorous 
sun avoidance and sun protection measures including the regular use of lip sunscreen and 
broad-brimmed hats should be emphasized. Given the diffuse and premalignant nature of 
actinic cheilitis, field therapy of the entire lip is recommended rather than focal treatment 
(Table 4). Topical therapies are indicated for diffuse and mild-moderate actinic cheilitis. 
However, there are no FDA approved medications for its treatment. For persistent disease 
with high-grade dysplasia, destructive therapies such as vermilionectomy or laser 
ablation are indicated. 
 
The prognosis of actinic cheilitis depends on the degree of dysplasia, patient risk factors, 
and immune status.
94, 95
 Actinic cheilitis has been shown to evolve to squamous cell 
carcinoma in 1.4%-36% of patients over variable time intervals (ranging from 1 to 30 
years).
91, 98, 99
 Therefore, clinical abnormalities that persist following appropriate 
treatment of actinic cheilitis warrant further diagnostic evaluation by histopathology. 
 
Squamous cell carcinoma of the lip 
 
Squamous cell carcinoma (SCC) of the lip is the most common oral neoplasm.
94, 100, 101
 
The lower lip is more commonly affected (89%). 
102,101
 SCC of the lip presents as 
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indurated, non-healing red or white papules or ulcers. It is usually asymptomatic and 
commonly occurs in areas of preexisting actinic cheilitis. (Figure 4) It is associated with 
chronic UV exposure, tobacco, alcohol exposure, and possibly HPV strains.
94, 100, 101
 
Organ transplant recipients have a 15-fold increased risk for developing lip cancer due to 
their immunosuppressed status.
94, 95
  
 
It is more common in fair-skinned Caucasians.
101
 Men are more commonly affected than 
women, though black men are rarely affected. 
101
 High risk HPV strains may play a role 
in the development of some lip SCCs, as HPV 16 and 18 are found in 6% of cases; 
however, these strains are also found in normal oral mucosa.
103
 Poor oral 
hygiene/dentition is associated with worse outcomes in patients with SCC.
104
 
 
Metastases may be present at the time of diagnosis as the lips are a site at high-risk for 
metastases (8% at time of diagnosis, 14% after 5 years following excision).
100, 105
 Lymph 
node metastases are often on the same side, enlarged, fixed and firm; later stage 
metastases are to the lung and liver. Staging must be performed at initial examination. 
The clinician should check for the presence of lymphadenopathy, assess size of the lymph 
nodes, whether nodes are fixed, and whether they are unilateral as well as signs of distant 
metastases such as cough, hepatosplenomegaly, or jaundice.  
 
The biologic behavior of lip SCC is related to location and risk factors. Risk of metastasis 
increases with tumors >2 cm in size, depth of invasion  >4 mm, recurrent lesions, 
perineural invasion, and in patients who are immunosuppressed.
106
 Lip cancer is 
considered to be separate from other oral cancers, of which tongue is the most common 
and is more likely to be deeply invasive or metastatic.
101
 
 
The differential diagnosis of lip SCC depends on the clinical appearance.  For a persistent 
nodule, neoplastic causes may be considered such as basal cell carcinoma, pyogenic 
granuloma, amelanotic melanoma, or actinic cheilitis. For a nonhealing ulcer, the 
differential diagnosis includes, vesiculobullous disorders, oral tuberculosis, syphilis and 
deep fungal infections. 
 
 
Proliferative verrucous leukoplakia (PVL) presents initially with innocuous intraoral 
white plaques; however, PVL is a distinct variant of oral leukoplakia characterized by the 
progression and expansion of multifocal plaques that develop an exophytic verrucous 
appearance.
107
 Women are significantly more likely to be affected than men (ratio 4:1).
107
 
Each site/lesion is at high risk for malignant transformation. In contrast to most oral and 
lip SCC, smoking has not been associated with PVL in most patients.
107
 Lip involvement 
has only rarely been reported. In one case, a patient with PVL was noted to also have 
involvement of a verrucous plaque on her lower lip, which extended onto the cutaneous 
surface.
108
 Histologic features are variable and range from epithelial dysplasia to 
verrucousSCC.
107, 108
  
 
The pathophysiology of lip SCC is due to malignant transformation of epithelial cells.
109
 
On pathology, actinic cheilitis is often found in lip SCC biopsies, suggesting a common 
etiology and strong relationship between the two. 
110,109 
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Treatment includes surgical excision with neck dissection for high grade tumors or those 
with palpable lymph nodes.
111, 112
 Radiation therapy has outcomes similar to surgery for 
lip tumors and is a good option for non-surgical candidates. Radiation therapy, however,  
does not allow for histologic confirmation.
113
 Adjuvant radiation or chemotherapy may 
be considered for patients with risk of residual disease or perineural invasion.
113
  
 
 
Conclusions 
 
The lips are highly visible and cosmetically important anatomic structures. Alterations 
may be distressing and disfiguring. Knowledge of the appropriate examination technique 
and recognition of normal and abnormal findings is necessary to evaluate the lips, which 
may display symptoms of systemic disease or pathology.  The number of mucocutaneous 
conditions that affect the lips is quite large and variable.  A complete evaluation is 
necessary in these patients. A careful history and physical examination, associated studies 
(biopsy, laboratory and microbiology tests), comprehensive review of medications, 
allergies, and habits all may be helpful. Treatment should be focused on eliminating 
potential irritant or allergens and treatment of the primary dermatosis. 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 20 
Tables and Figures 
 
Table 1 Differential Diagnosis of Inflammatory Cheilitis 
Common  Rare 
Actinic 
Allergic 
Atopic 
Candidiasis 
Herpes simplex virus infection 
Irritant (lip lickers, wind burn) 
Lichen planus 
Discoid lupus erythematosus 
Psoriasis 
Drug-induced 
EM/SJS 
Morsicatio labiorum 
Amyloidosis 
Acanthosis nigricans 
Cheilitis granulomatosa (Miescher’s 
cheilitis) 
Sarcoidosis 
Cheilitis glandularis  
Plasma cell cheilitis 
Syphilis 
Exfoliative cheilitis 
 
Table 2 Differential Diagnosis of Lip Neoplasms 
Benign  Malignant 
Molluscum contagiosum 
Leukoplakia 
Verruca 
Venous lake 
Labial melanotic macules 
Lymphangioma 
Hemangioma  
 
Proliferative verrucous leukoplakia 
Malignant melanoma  
Squamous cell carcinoma 
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Table 3. Contact Cheilitis  
Allergic Irritant 
Rare Very common 
T-cell mediated, type IV or 
delayed hypersensitivity 
immunologic reaction  
Nonspecific inflammatory 
reaction  
 
 
Clinical disease occurs 24 
to 48 hours after exposure 
 
Environmental factors, sun, 
cold and wind, lip licking, 
drooling and pooling of 
saliva 
 
Precipitating etiology may 
be obvious or not… 
 
 
Pathology   nonspecific 
or lichenoid; eosinophils 
 
Pathology   nonspecific 
or lichenoid 
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Table 4: Treatment of Actinic Cheilitis  
Treatment Advantages Disadvantages 
Topical 5-fluorouracil
114
 
  -5% solution TID x 9-15 days 
 -5% cream BID x 2-4 weeks 
Complete healing 2-3 
weeks post-treatment 
Discomfort, pain, erosions 
No histologic analysis 
Topical diclofenac Less irritating than 
topical fluorouracil or 
imiquimod 
Longer treatment times 
Topical imiquimod
115
 Persistent clearance 
after treatment period
116
 
Irritation, erythema, 
induration, erosions, 
ulceration 
Topical imgenol mebutate  Limited data 
Photodynamic therapy with 
methyl/aminolevulinic acid
117, 
118
 
Good safety profile 
Better cosmetic 
outcome 
Low complete response rate 
even with multiple 
treatments 
Liquid nitrogen cryosurgery
119
 Best for localized 
actinic lesions 
No histologic analysis 
Electrodessication Best for localized 
actinic lesions 
No histologic analysis 
CO2 laser vaporization Normal lip contour, no 
“significant” scarring 
No histologic analysis 
Vermilionectomy (“lip 
shave”)120 
Removes entire 
vermilion lip 
Histologic analysis 
Paresthesia (25%), pruritus 
(7.7%), labial scar tension 
(15.4%), 7.6% labial scar 
pain
121
 
Requires specific surgical 
expertise 
 
Abbreviations  
AIDS Acquired Immunodeficiency Syndrome 
BID Twice daily 
CDC Center for Disease Control 
DFA Direct Fluorescence Antigen 
DNA Deoxyribonucleic Acid 
EM Erythema Multiforme 
GI Gastrointestinal 
HIV Human Immunodeficiency Virus 
HMB Human Melanoma Black 
HPV Human Papillomavirus  
HSV Herpes Simplex Virus 
mm Millimeters  
PCR Polymerase Chain Reaction 
QD Daily 
SCC Squamous Cell Carcinoma 
SJS Stephen-Johnson Syndrome 
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UV Ultraviolet  
VWS Van der Woude Syndrome 
WHO World Health Organization 
KOH Potassium Hydroxide 
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Figure 1 Angular Cheilitis in the setting of Oral Candidiasis (From the collection of Dr. 
Ginat Mirowski) 
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Figure 2 Lip Lickers Cheilitis (From the collection of Dr. Ginat Mirowski) 
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Figure 3 Discoid Lupus Cheilitis (From the collection of Dr. Ginat Mirowski) 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 27 
Figure 4 Squamous cell carcinoma in the setting of chronic actinic cheilitis ((From 
the collection of Indiana University School of Dentistry) 
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